Next Article in Journal

Bevacizumab-Based Therapies in Malignant Tumors—Real-World Data on Effectiveness, Safety, and Cost

Next Article in Special Issue

Possibilities of Overcoming Resistance to Osimertinib in NSCLC Patients with Mutations in the EGFR Gene

Previous Article in Journal

Correction: Krayem et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance. Cancers 2020, 12, 512

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessArticle

Article Versions Notes

Cancers 2024, 16(14), 2589; https://doi.org/10.3390/cancers16142589

Action	Date	Notes	Link
article pdf uploaded.	19 July 2024 16:32 CEST	Version of Record	https://www.mdpi.com/2072-6694/16/14/2589/pdf-vor
article supplementary file uploaded.	19 July 2024 16:32 CEST	-	https://www.mdpi.com/2072-6694/16/14/2589#supplementary
article xml file uploaded	22 July 2024 08:03 CEST	Original file	-
article xml uploaded.	22 July 2024 08:03 CEST	Update	https://www.mdpi.com/2072-6694/16/14/2589/xml
article pdf uploaded.	22 July 2024 08:03 CEST	Updated version of record	https://www.mdpi.com/2072-6694/16/14/2589/pdf
article html file updated	22 July 2024 08:05 CEST	Original file	-
article html file updated	26 June 2025 10:04 CEST	Update	https://www.mdpi.com/2072-6694/16/14/2589/html

Back to TopTop